Clinical Evidence for the Stereotaxis Niobe® Magnetic Navigation System: Advantages of Electrophysiology (EP) Ablation
Download the Full Clinical Evidence Summary
Approximately 180 leading global hospitals have adopted the Niobe® Magnetic Navigation System (MNS) for EP ablation. The current Niobe MNS is a 4th Generation system, an evolution from earlier Stereotaxis clinical systems. To date, over 100,000 EP procedures have been performed with magnetic navigation. Of the estimated 280 total peer-reviewed scientific publications highlighting remote magnetic navigation technology listed in Stereotaxis’ PRO-240, more than 85% of the publications discuss its use in cardiac EP procedures and are featured in peer-reviewed journals such as the Journal of Cardiovascular Electrophysiology, PACE, Europace, the Journal of American College of Cardiology, and the Journal of Interventional Cardiac Electrophysiology. This body of clinical research, resulting journal publications and physician advocacy has led to greater market access, regulatory and reimbursement support, and provider adoption.
This peer-reviewed published research with Stereotaxis’ innovative technologies and published papers have established overwhelming evidence supporting magnetic navigation’s clinical benefits, including:
- Improving long-term patient clinical outcomes (atrial fibrillation [AF], ventricular tachycardia [VT], and congenital heart disease treatment)
- Continued improvements in procedural efficiency through reduced treatment times and improved patient work flow when compared to older Niobe systems
- Excellent patient safety due to the flexible catheter shaft
- Low X-ray fluoroscopic radiation for physicians, laboratory staff and patients (especially for the vulnerable pediatric population)